Afuco™ Anti-Human LILRB3 ADCC Therapeutic Antibody (TRX585), ADCC Enhanced
Anti-LILRB3 ADCC Enhanced Antibody (TRX585) is an ADCC enhanced antibody produced by our Afuco™ platform. TRX585 is a novel monoclonal antibody that targets ILT5, specific for immunoglobulin-like transcript 5. It may be useful in the treatment of viral infections and malignancies.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-472CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | LILRB3 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at -20°C. Avoid multiple freeze/thaw cycles. |